Connection

Sara Giordano to Odds Ratio

Back to Details
This is a "connection" page, showing publications Sara Giordano has written about Odds Ratio.
Sara Giordano
Connection Strength
0.028
Odds Ratio
  1. Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579). Breast Cancer Res Treat. 2015 Jun; 151(3):629-38.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.